Erlotinib Sandoz

Erlotinib Sandoz is an oral medication used for targeted therapy in certain types of cancer. This pharmaceutical is designed to inhibit specific proteins involved in cancer cell growth.

Erlotinib Sandoz is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. This medication is often prescribed when other treatments have not been effective or when the cancer has specific genetic markers.

Common effects of Erlotinib Sandoz may include skin rash, diarrhea, and fatigue. Some users may also experience appetite loss, nausea, or dry skin. These effects can vary in severity and may not affect everyone who takes the medication.

Erlotinib Sandoz should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may cause dizziness or fatigue, so it is advisable to avoid activities that require alertness until you know how it affects you.

Erlotinib Sandoz may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.